2269 — WuXi Biologics (Cayman) Cashflow Statement
0.000.00%
- HK$93.97bn
- HK$91.72bn
- CNY18.68bn
- 78
- 28
- 99
- 80
Annual cashflow statement for WuXi Biologics (Cayman), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 1,966 | 3,993 | 5,358 | 4,174 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 73.8 | 270 | 943 | 1,003 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -461 | -1,313 | -1,560 | -1,679 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,881 | 3,431 | 5,542 | 4,668 | — |
Capital Expenditures | -6,025 | -6,523 | -5,868 | -4,221 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,192 | -3,079 | -39.9 | 992 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -7,216 | -9,602 | -5,908 | -3,228 | — |
Financing Cash Flow Items | 160 | -104 | 508 | 92.6 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6,566 | 8,209 | -2,592 | 1,961 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 890 | 1,908 | -2,608 | 3,275 | — |